Pharmaceutical preparations for use in the treatment of autoimmune disease, multiple sclerosis and ulcerative colitis

Pharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

Administration of patient reimbursement programs in connection ozanimod; administering pharmacy reimbursement programs and services in connection ozanimod

Pharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; all of the foregoing being immunomodulators